|
|
||||||||
Michael Reese Hospital and Medical Center, and University of Illinois at the Medical Center, Chicago, Illinois
Correspondence: For reprints contact: Carlos Bekerman, MD, Division of Nuclear Medicine, Michael Reese Hospital and Medical Center, 31st St. & Lake Shore Drive, Chicago, IL 60616.
ABSTRACT
Alteration of the gallium-67 (Ga-67) distribution after administration of chemotherapeutic agents has been demonstrated in experiments on both normal and tumor-bearing animals. We have encountered eight patients who had Ga-67 scintigrams in which the findings were similar to those in the animals experiments: markedly increased uptake in bone, with suppressed uptake in liver, muscle, and tumor. Five of the patients had hematologic neoplasms, and three had solid tumors, and each had received one or more chemotherapeutic agents during the 24 hr preceding Ga-67 administration. In three patients while not on antineoplastic medication subsequent Ga-67 images showed a return to the usual Ga-67 distribution patient. The altered Ga-67 distribution may result from inhibition of protein synthesis or of a serum-binding agent for Ga-67, or from competitive blockage of specific Ga-67 organ receptors by the antineoplastic agents.
This article has been cited by other articles:
![]() |
M L Gomes, D M. de mattos, R de souza freitas, R J. Bezerral, and M Bernardo-Filho Study of the toxicological effect of mitomycin C in mice: alteration on the biodistribution of radiopharmaceuticals used for renal eva uations Human and Experimental Toxicology, April 1, 2001; 20(4): 193 - 197. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |